IQVIA HOLDINGS INC. Proceeds from Issuance of Debt
IQVIA HOLDINGS INC. (IQV) reported Proceeds from Issuance of Debt of $650.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-05-05
- IQVIA HOLDINGS INC. proceeds from issuance of debt for the quarter ending 2026-03-31 was $650.00M, a 67.25% decline year-over-year.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for the quarter ending 2025-12-31 was $2.48B.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for the quarter ending 2025-09-30 was $0.00.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for the quarter ending 2025-06-30 was $2.00B.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for fiscal 2025 was $6.46B.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for fiscal 2023 was $4.00B, a 220.00% increase from fiscal 2022.
- IQVIA HOLDINGS INC. proceeds from issuance of debt for fiscal 2022 was $1.25B, a 35.93% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month | Proceeds from Issuance of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $650.00M 10-Q · filed 2026-05-05 | $3.13B derived: sum of 2 quarters · filed 2026-05-05 | $3.13B derived: sum of 3 quarters · filed 2026-05-05 | $5.13B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | $2.48B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.48B derived: sum of 2 quarters · filed 2026-02-17 | $4.48B derived: sum of 3 quarters · filed 2026-02-17 | $6.46B 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.00B derived: sum of 2 quarters · filed 2025-10-28 | $3.98B 10-Q · filed 2025-10-28 | $3.98B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-06-30 | $2.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $3.98B 10-Q · filed 2025-07-22 | $3.98B derived: sum of 3 quarters · filed 2026-05-05 | $3.98B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-03-31 | $1.99B 10-Q · filed 2026-05-05 | $1.99B derived: sum of 2 quarters · filed 2026-05-05 | $1.99B derived: sum of 3 quarters · filed 2026-05-05 | $1.99B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | $2.75B derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $0.00 10-Q · filed 2025-07-22 | $2.75B derived: sum of 3 quarters · filed 2026-02-17 | $2.75B derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | $2.75B derived: sum of 2 quarters · filed 2026-02-17 | $2.75B derived: sum of 3 quarters · filed 2026-02-17 | ||
| 2023-12-31 | $2.75B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.75B derived: sum of 2 quarters · filed 2026-02-17 | $4.00B 10-K · filed 2026-02-17 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.25B 10-Q · filed 2024-10-31 | |||
| 2023-06-30 | $1.25B 10-Q · filed 2024-07-22 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $1.25B derived: sum of 3 quarters · filed 2025-02-13 | $1.25B 10-K · filed 2025-02-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.25B derived: sum of 2 quarters · filed 2023-11-01 | $1.25B 10-Q · filed 2023-11-01 | $1.25B derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $1.25B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $1.25B 10-Q · filed 2023-08-01 | $1.25B derived: sum of 3 quarters · filed 2024-02-15 | $1.45B derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $200.00M derived: sum of 3 quarters · filed 2024-02-15 | $200.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $200.00M derived: sum of 2 quarters · filed 2024-02-15 | $200.00M derived: sum of 3 quarters · filed 2024-02-15 | $1.95B 10-K · filed 2024-02-15 | |
| 2021-09-30 | $200.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $200.00M derived: sum of 2 quarters · filed 2022-10-27 | $1.95B 10-Q · filed 2022-10-27 | $1.95B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $1.75B 10-Q · filed 2022-07-22 | $1.75B derived: sum of 3 quarters · filed 2023-02-15 | $1.75B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-03-31 | $1.75B 10-Q · filed 2022-04-28 | $1.75B derived: sum of 2 quarters · filed 2023-02-15 | $1.75B derived: sum of 3 quarters · filed 2023-02-15 | $2.54B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $1.00M derived: sum of 2 quarters · filed 2023-02-15 | $791.00M derived: sum of 3 quarters · filed 2023-02-15 | $1.59B 10-K · filed 2023-02-15 | |
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $791.00M derived: sum of 2 quarters · filed 2021-10-22 | $1.59B 10-Q · filed 2021-10-22 | $1.59B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | $790.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.59B 10-Q · filed 2021-07-28 | $1.59B derived: sum of 3 quarters · filed 2022-02-16 | $2.39B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $800.00M 10-Q · filed 2021-04-23 | $800.00M derived: sum of 2 quarters · filed 2022-02-16 | $1.60B derived: sum of 3 quarters · filed 2022-02-16 | $2.70B derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $800.00M derived: sum of 2 quarters · filed 2022-02-16 | $1.90B derived: sum of 3 quarters · filed 2022-02-16 | $1.90B 10-K · filed 2022-02-16 | |
| 2019-09-30 | $800.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $1.90B derived: sum of 2 quarters · filed 2020-10-22 | $1.90B 10-Q · filed 2020-10-22 | $1.90B derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | $1.10B derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $1.10B 10-Q · filed 2020-07-23 | $1.10B derived: sum of 3 quarters · filed 2021-02-12 | $1.10B derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $1.63B 10-K · filed 2021-02-12 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $1.63B 10-Q · filed 2019-11-01 | |||
| 2018-06-30 | $1.63B 10-Q · filed 2019-07-24 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.24B derived: sum of 2 quarters · filed 2020-02-18 | $1.24B derived: sum of 3 quarters · filed 2020-02-18 | $5.24B 10-K · filed 2020-02-18 | |
| 2017-09-30 | $1.24B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $1.24B derived: sum of 2 quarters · filed 2018-10-25 | $5.24B 10-Q · filed 2018-10-25 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $4.00B 10-Q · filed 2018-07-27 | |||
| 2017-03-31 | $4.00B 10-Q · filed 2018-05-04 | ||||
| 2016-12-31 | $466.00M 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $500.00K derived: sum of 2 quarters · filed 2018-02-16 | $2.25B 10-K · filed 2018-02-16 | $2.25B 10-K · filed 2016-02-11 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.25B 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | $2.25B 10-Q · filed 2016-07-27 | ||||
| 2014-12-31 | $275.00M 10-K · filed 2017-02-16 | ||||
| 2013-12-31 | $2.06B 10-K · filed 2016-02-11 | ||||
| 2012-12-31 | $2.15B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $2.15B derived: sum of 2 quarters · filed 2015-02-12 | $2.15B derived: sum of 3 quarters · filed 2015-02-12 | $2.44B 10-K · filed 2015-02-12 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$20.00K derived: sum of 2 quarters · filed 2013-10-31 | $287.79M 10-Q · filed 2013-10-31 | ||
| 2012-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $287.79M 10-Q · filed 2013-08-01 | |||
| 2012-03-31 | $287.81M 10-Q · filed 2013-05-14 | ||||
| 2011-12-31 | $1.98B 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |